Merck vaccines contaminated with plastic, says FDA

August 2, 2011
Manufacturing and Production Contamination, Merck & Co, vaccines

Vaccines made by Merck & Co at its West Point facility in Philadelphia, US, have been found to be contaminated …

Quintiles launches first salesforce in Russia

August 2, 2011
Sales and Marketing CSO, Quintiles, Russia, emerging markets

 Quintiles is set to launch its first contract sales project in Russia with a 40 strong sales team.  The company …

Daiichi Sankyo Selects Veeva CRM to Support Customer Engagement Initiatives in the UK

August 1, 2011

BARCELONA, SPAIN and GERRARDS CROSS, BUCKS, UK – 26 July, 2011 – Veeva Systems announced today that Daiichi Sankyo, one …

Figure 1

T Wave Indices of Drug Induced Changes in Repolarisation

August 1, 2011

For the past decade prolongation  of the QT interval  has been  used by the regulatory agencies as the principal biomarker …

Once daily Viramune set for approval in Europe

August 1, 2011
Sales and Marketing Boehringer Ingelheim, HIV

European regulators have recommended the approval of a new, once-daily form of Boehringer Ingelheim’s HIV treatment Viramune. Viramune (nevirapine) has …

FDA building

FDA refuses to file Eisai’s epilepsy drug

August 1, 2011
Sales and Marketing Eisai, FDA, epilepsy

The FDA has refused to file Eisai’s epilepsy drug perampanel, saying it needs more information for the treatment. The FDA …

Merck KGaA appoints Udit Batra

August 1, 2011
Sales and Marketing appointment, sales and marketing

Udit Batra is to join Merck KGaA as head of its consumer health care division on 1 September. He moves …

Shire sales rocket with 25% growth

July 29, 2011
Sales and Marketing ADHD, Fabry disease, Gaucher's disease, Shire

Specialist pharma company Shire has posted exceptionally strong results for the second quarter, increasing its product sales by 30% and …

Witty backs Britain as manufacturing, R&D location

July 29, 2011
Manufacturing and Production, Research and Development GSK

GlaxoSmithKline chief executive Andrew Witty has promised to expand operations in the UK in both manufacturing and R&D, saying that …

Red Door appoints Julia Holt

July 29, 2011
Medical Communications appointment, medical communcations

Julia Holt has joined Red Door Communications from Apothecom Huntsworth Health as an associate director and member of the management …

Ex-LeapFrog employees launch med comms agency

July 29, 2011
Medical Communications medical communications news

A quartet of former employees at LeapFrog have banded together to launch a new UK med comms agency. Bamboo Medical …

Sanofi

Sanofi battles strong headwinds in second quarter

July 29, 2011
Sales and Marketing Sanofi

Sanofi’s acquisition of Genzyme helped its revenue grow in the second quarter, but underlying growth from the French firm disappointed. …

Prescription sales soar in England

July 29, 2011
Sales and Marketing NHS, prescribing

New data shows that prescription sales increased by more than two-thirds in England over the last decade, but a majority …

Sanofi appoints head of strategy

July 28, 2011
Sales and Marketing appointment, sales and marketing

Dr David-Alexandre Gros has joined Sanofi as chief strategy officer with a remit that covers all the group’s business development …

Lilly

Lilly releases details of US doctor payments

July 28, 2011
Medical Communications, Sales and Marketing industry reputation, lilly

Lilly has released details of its payments to doctors and healthcare organisations in the US. The company paid $48.1 million …

Sir John Oldham

A chronic problem for the health service

July 27, 2011
Sales and Marketing NHS, long term conditions

Sir John Oldham is not widely known outside the Department of Health, but he might just have the most difficult …

GlaxoSmithKline

GSK sales down on Avandia and pandemic products

July 27, 2011
Research and Development, Sales and Marketing GSK

GlaxoSmithKline has posted a slide in revenue for the second quarter, but is buoyed by strong underlying growth. Sales were …

Janssen's Velcade (bortezomib)

NICE recommends thalidomide ahead of Velcade

July 27, 2011
Sales and Marketing NICE, Thalidomide, Velcade

NICE has recommended Celgene’s thalidomide ahead of J&J’s Velcade for multiple myeloma. Celgene’s drug is recommended in combination with an …

Contract research news in brief

July 27, 2011
Research and Development research and development news

PPD plays down sell-off rumours, Icon sees a steep profit decline, plus updates from Beaufort, PharmaNet, ClinStar and Biofocus/IMD. PPD …

Open Health appoints three new partners

July 26, 2011
Medical Communications apppointment, medical communications

New UK comms agency Open Health has strengthened its management team, appointing three new partners. Andy Bell, Cory Inglis and …

The Gateway to Local Adoption Series

Latest content